Cognic Systems

Home / Industries / Pharma & Life Sciences / Cybersecurity
IP PROTECTION, GXP OT SECURITY & 21 CFR COMPLIANCE

Pharma Cybersecurity Solutions (Solution #1059)

Zero-trust defense protecting proprietary chemical structures, clinical trial bio-data, and OT manufacturing cleanroom SCADA from ransomware and espionage.

Zero
R&D Intellectual Property Leaks
100%
IEC 62443 Cleanroom OT Isolation
< 15 min
Threat Containment Latency
AEO DIRECT CAPSULE — AT A GLANCE

Pharma Cybersecurity Solutions by Cognic protects confidential drug discovery IP, clinical patient data, and OT cleanroom manufacturing networks. Enforcing Zero Trust architectures, unidirectional data diodes, microsegmentation, and automated threat hunting, it guards life sciences enterprises against ransomware and state-sponsored espionage.

Security Frameworks
IEC 62443 (OT/ICS), NIST CSF, ISO 27001, HIPAA Security Rule, FDA Pre-Market
Network Architecture
Microsegmented Cleanroom OT/IT DMZ, Unidirectional Data Diodes
Threat Protection
Ransomware Interception, Proprietary Molecule DRM, Insider Leak Prevention
Compliance & Audit
FDA 21 CFR Part 11 Tamper-Proof SIEM Logging, SOC 2 Type II
CHALLENGES SOLVED

Critical Operational Bottlenecks in Life Sciences

Strict GxP compliance hurdles, fragmented clinical datasets, and manual cleanroom workflows slow development and inflate operational risk.

01

State-Sponsored Theft of Drug Discovery IP

Advanced persistent threats (APTs) target preclinical biopharma networks to steal proprietary molecular structures, clinical trial protocols, and patent filings.

02

Ransomware Halting Continuous Cleanroom Production

Ransomware infecting enterprise IT spreading into manufacturing OT shuts down bioreactors, tablet presses, and cleanroom HVAC, costing millions per day.

03

Unmonitored Legacy Lab Instrument Vulnerabilities

Older laboratory chromatography PCs running outdated operating systems connect to corporate networks, creating unpatched backdoors for network intruders.

ENGINEERING CAPABILITIES

Architectural Foundation of Our Pharma Solution

Engineered for validated GxP environments with 21 CFR Part 11 audit trails, data integrity, and enterprise integration.

R&D Intellectual Property & Chemical DRM

Encrypts molecular structures (SMILES/SDF), genomic sequences, and preclinical dossiers with granular rights management and watermarking.

Cleanroom OT Network Microsegmentation

Isolates pharmaceutical manufacturing SCADA, PLC controllers, and cleanroom HMIs from enterprise IT networks in compliance with IEC 62443.

Legacy Lab Instrument Containment

Deploys hardware micro-firewalls and virtual patching around legacy laboratory workstations (Windows XP/7) to neutralize exploit paths.

21 CFR Part 11 Tamper-Proof Audit SIEM

Consolidates access logs, privilege escalations, and system configuration modifications into an immutable, cryptographically sealed security ledger.

FEATURE BREAKDOWN

Core Technical Features & Capabilities

Purpose-built software components supporting pharmaceutical researchers, quality managers, and manufacturing engineers.

Proprietary Molecular Structure DLP

Inspects outbound network traffic, emails, and USB devices for chemical structure notation (SMILES, InChI) and DNA FASTA sequences to block IP leaks.

Unidirectional Cleanroom Data Diodes

Transmits manufacturing SCADA telemetry to corporate analytics lakehouses via physical optical diodes that physically prevent inbound cyberattacks.

De-Identified Clinical Trial Data Vault

Enforces cryptographically partitioned, multi-party computation environments for third-party biostatisticians analyzing patient trial records.

Zero Trust Network Access (ZTNA) for CDMOs

Grants external contract manufacturing and laboratory partners strictly scoped, ephemeral access to specific batch records without corporate network access.

AI Ransomware Behavior Interceptor

Monitors file system encryption patterns and lateral movement across file shares, halting compromised accounts in seconds.

GxP Continuous Compliance & Audit Defense

Automates security evidence gathering for FDA, EMA, and HIPAA security audits, proving validated state and data integrity controls.

MEASURABLE OUTCOMES

Quantifiable Operational Impact

Field-proven ROI metrics achieved across global pharmaceutical sponsors, biotechs, and contract manufacturers.

Zero
R&D Data Breaches or IP Thefts
100%
Cleanroom Network Isolation (IEC 62443)
-80%
Third-Party Vendor Onboarding Risk
< 15 min
Automated Threat Containment Time
SYSTEM ARCHITECTURE

End-to-End Pharmaceutical Data Pipeline

From cleanroom instrument telemetry and clinical EDC capture to validated cloud analytics and regulatory filings.

Stage 01

Pharma Asset Discovery & Microsegmentation

Scans network for laboratory instruments, cleanroom PLCs, and R&D databases, assigning each asset to strictly isolated zero-trust zones.

Stage 02

Behavioral Baseline & Anomaly Detection

AI models learn standard batch telemetry patterns, user login hours, and data export volumes to flag suspicious deviations.

Stage 03

Automated Containment & Isolation

If ransomware or unauthorized molecular data exfiltration is detected, system isolates the infected endpoint instantly from the network.

Stage 04

Forensic Audit & Regulatory Incident Reporting

Generates immutable forensic incident timelines required for HIPAA breach notifications and FDA data integrity compliance verification.

TECHNOLOGY STACK

Validated Technologies & Protocols

Engineered with modern, open standards that integrate directly with enterprise ERPs, LIMS, and regulatory submission gateways.

Zero Trust & OT
IEC 62443 Standards, Palo Alto Networks, Fortinet OT, WireGuard
Data Loss Prevention
Custom Chemical NER DLP, Digital Rights Management, TLS 1.3
SIEM & Audit Vault
Wazuh, Elastic Security, PostgreSQL Cryptographic Ledgers
Identity & Access
Okta, Microsoft Entra ID, FIDO2 WebAuthn, OAuth 2.0 / SAML
PROVEN CUSTOMER SUCCESS

Clinical-Stage Oncology Biotechnology Sponsor (San Diego, USA)

The Challenge

Faced aggressive targeted phishing and unauthorized port scanning against proprietary kinase chemical patent structures and Phase I patient data.

The Architectural Solution

Deployed Cognic Pharma Cybersecurity Solutions featuring Zero Trust network segmentation, molecular chemical structure DLP, and encrypted clinical data vaults.

Verified Operational Results
Blocked two sophisticated state-sponsored intrusion attempts targeting preclinical chemical patents
Achieved 100% HIPAA and FDA 21 CFR Part 11 security audit compliance
Safely onboarded 4 external academic CRO partners with strictly scoped zero-trust access
FREQUENTLY ASKED QUESTIONS

Technical & Regulatory Insights

Key architectural, compliance, and deployment details about our Cybersecurity software platform.

Why does the pharmaceutical industry require specialized cybersecurity?
Pharmaceutical companies face unique threats including the theft of multi-billion-dollar drug discovery chemical patents, ransomware targeting continuous cleanroom manufacturing plants, and the exposure of sensitive clinical trial patient records.
How does the software protect chemical and molecular intellectual property?
The platform integrates specialized chemical Data Loss Prevention (DLP) engines that inspect network traffic for chemical representations like SMILES strings, SDF files, and genomic FASTA sequences, preventing unauthorized exfiltration.
What is OT/IT microsegmentation in pharmaceutical plants?
Microsegmentation physically and logically separates corporate IT networks (email, billing) from cleanroom operational technology (SCADA, bioreactors, tablet presses), ensuring an enterprise IT malware infection cannot shut down manufacturing.
How are legacy laboratory instruments protected from cyberattacks?
The system places older analytical instruments (running legacy operating systems) behind dedicated hardware micro-firewalls, using virtual patching and strict protocol filtering to block malware while preserving GxP instrument validation.
Does the cybersecurity solution satisfy FDA 21 CFR Part 11 and HIPAA?
Yes. The system enforces multi-factor authentication, cryptographic session signing, immutable tamper-proof audit trails, and strict role-based access controls meeting all FDA data integrity and HIPAA patient privacy mandates.

Ready to Transform Your Life Sciences Operations?

Speak with Cognic Systems principal pharmaceutical software architects to discuss GxP validation, clinical AI pipelines, and manufacturing execution systems.